Live Breaking News & Updates on Nasdaq Crbp

Stay updated with breaking news from Nasdaq crbp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Oppenheimer Raises Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $51.00

Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) had its price objective increased by Oppenheimer from $20.00 to $51.00 in a research note published on Monday, Benzinga reports. Oppenheimer currently has an outperform rating on the biopharmaceutical company’s stock. Separately, StockNews.com started coverage on shares of Corbus Pharmaceuticals in a research report on Friday, January 26th. They […] ....

Corbus Pharmaceuticals Holdings Inc , Corbus Pharmaceuticals , Institutional Investors Weigh In On Corbus Pharmaceuticals , Corbus Pharmaceuticals Company Profile , Corbus Pharmaceuticals Trading , News Ratings For Corbus Pharmaceuticals Daily , Vident Investment Advisory , Securities Exchange Commission , Renaissance Technologies , Dimensional Fund Advisors , Free Report , Get Free Report , Cormorant Asset Management , Exchange Commission , Sigma Investments , Fund Advisors , Investment Advisory , Street Corp , Pharmaceuticals Holdings , Corbus Pharmaceuticals Daily , Nasdaq Crbp , Boost Price Target , Oppenheimer Holdings Inc ,

Corbus Pharmaceuticals (NASDAQ:CRBP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Corbus Pharmaceuticals Trading Up 6.5 % NASDAQ:CRBP opened at $6.16 on Monday. The company has a market capitalization of $27.25 million, a P/E […] ....

News Ratings For Corbus Pharmaceuticals Daily , Vident Investment Advisory , Corbus Pharmaceuticals , Corbus Pharmaceuticals Trading , Sio Capital Management , Corbus Pharmaceuticals Holdings Inc , Dimensional Fund Advisors , Blackrock Inc , Institutional Investors Weigh In On Corbus Pharmaceuticals , Free Report , Get Free Report , Fund Advisors , Street Corp , Investment Advisory , Pharmaceuticals Holdings , Corbus Pharmaceuticals Daily , Nasdaq Crbp , Initiated Coverage , Stocknews Com ,

Corbus Pharmaceuticals (NASDAQ:CRBP) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com started coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report) in a note issued to investors on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Corbus Pharmaceuticals Stock Up 3.6 % Shares of CRBP stock opened at $5.50 on Monday. The business has a 50 […] ....

Dimensional Fund Advisors , Renaissance Technologies , News Ratings For Corbus Pharmaceuticals Daily , Corbus Pharmaceuticals Stock , Corbus Pharmaceuticals , Vident Investment Advisory , Corbus Pharmaceuticals Holdings Inc , Hedge Funds Weigh In On Corbus Pharmaceuticals , Get Free Report , Sigma Investments , Fund Advisors , Investment Advisory , Street Corp , Pharmaceuticals Holdings , Corbus Pharmaceuticals Daily , Nasdaq Crbp , Initiated Coverage , Stocknews Com ,